Prevalence and associated factors of gestational diabetes mellitus among women with polycystic ovary syndrome: a systematic review and meta-analysis - Scorecard - MDSpire
Advertisement
Prevalence and associated factors of gestational diabetes mellitus among women with polycystic ovary syndrome: a systematic review and meta-analysis
Clinical Scorecard: Assessment of Gestational Diabetes Mellitus Prevalence and Contributing Factors in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Gestational Diabetes Mellitus in Polycystic Ovary Syndrome
Key Mechanisms
Insulin resistance, pre-pregnancy BMI, gestational weight gain, family history of diabetes
Target Population
Women with Polycystic Ovary Syndrome
Care Setting
Clinical assessment and management of gestational diabetes
Key Highlights
Pooled GDM prevalence in PCOS is 24% with significant heterogeneity.
Primary prevalence estimate from cohort studies is 21.7%.
Associated factors include HOMA-IR, family history of diabetes, pre-pregnancy BMI, and gestational weight gain.
Guideline-Based Recommendations
Diagnosis
Utilize one-step and two-step methods for GDM diagnosis.
Management
Consider early monitoring of glucose metabolism and weight management in PCOS patients.
Monitoring & Follow-up
Regular assessment of glucose levels and weight during pregnancy.
Risks
Increased risk of fetal macrosomia, neonatal hypoglycemia, and long-term metabolic syndrome in offspring.
Patient & Prescribing Data
Women diagnosed with Polycystic Ovary Syndrome.
Management strategies should focus on monitoring and addressing metabolic risks.
Clinical Best Practices
Implement targeted screening for GDM in women with PCOS.
Utilize evidence-based guidelines for the diagnosis and management of GDM.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
